Showing results (11-20 of 64) with videos related to
Sort By:
Pageof 7
BMC Cancer|September 24, 2020
Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancerAmber Blaauboer, Stephanie Booy, Peter M van Koetsveld, et al.Journal of Medicinal Chemistry|October 14, 2005
Discovery of iodinated somatostatin analogues selective for hsst2 and hsst5 with excellent inhibition of growth hormone and prolactin release from rat pituitary cellsSandra Blaj Moore, Joost van der Hoek, Antonia de Capua, et al.The Journal of Clinical Endocrinology and Metabolism|October 6, 2019
The Efficacy of Mitotane in Human Primary Adrenocortical Carcinoma CulturesPeter M van Koetsveld, Sara G Creemers, Fadime Dogan, et al.Frontiers in Oncology|July 22, 2021
Modifying Effects of Glucose and Insulin/Insulin-Like Growth Factors on Colon Cancer CellsŞeyda Berk, Joseph A M J L Janssen, Peter M van Koetsveld, et al.Reviews in Endocrine & Metabolic Disorders|July 8, 2008
Potential role of type I interferons in the treatment of pituitary adenomasGiovanni Vitale, Michele Caraglia, Peter M van Koetsveld, et al.European Journal of Endocrinology|December 21, 2024
Digital quantification of somatostatin receptor subtypes 2 and 5 in growth hormone-secreting pituitary tumorsClaudia Campana, Jessica Amarù, Angelo Milioto, et al.Pancreas|July 30, 2014
Type I Interferon Receptor Expression in Human Pancreatic and Periampullary Cancer TissueStephanie Booy, Leo J Hofland, A Marlijn Waaijers, et al.The Journal of Clinical Endocrinology and Metabolism|January 5, 2021
Levoketoconazole, the 2S,4R Enantiomer of Ketoconazole, a New Steroidogenesis Inhibitor for Cushing's Syndrome TreatmentSara G Creemers, Richard A Feelders, Frank H de Jong, et al.The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune systemVirgil A Dalm, P Martin van Hagen, Peter M van Koetsveld, et al.International Journal of Oncology|July 7, 2022
Immunomodulatory antitumor effect of interferon‑beta combined with gemcitabine in pancreatic cancerAmber Blaauboer, Peter M Van Koetsveld, Dana A M Mustafa, et al.Pageof 7